Skip to main content

Greenberg Traurig’s Rose Cordero Prey and Andrew Tsui Appointed to UNC-Chapel Hill Board of Visitors

NEW YORK — June 8, 2023 – Rose Cordero Prey and Andrew Tsui, attorneys at global law firm Greenberg Traurig, LLP, were selected to serve on the University of North Carolina at Chapel Hill Board of Visitors for a four-year term beginning July 1.

According to UNC News, “Selected members serve as ambassadors to inform their communities about the University’s priorities and, in turn, educate the University on how it can best serve communities around the world. Members also offer their professional expertise and experience to recruit top-tier students to Carolina, mentor current students as they navigate their transition to the workforce and respond to the need for ongoing communication with local, state and federal leaders.”

Prey, a shareholder in the firm’s Intellectual Property & Technology Practice in New York, is a first chair trial lawyer who counsels clients on invention protection, portfolio management, patent litigation, licensing, and due diligence in the mechanical, electrical, computer science, and life science industries. With almost 20 years of experience in high tech intellectual property litigation, she has represented both plaintiffs and defendants in patent infringement cases involving a wide array of technologies from smartphone software and fintech, to semiconductor fabrication and lithium-ion technology, to cellular immunotherapies.

Tsui, of counsel in the firm’s Health Care & FDA Practice in Washington, D.C., spent over a decade of his career litigating on behalf of the U.S. Department of Health and Human Services, Office of the General Counsel for the Centers for Medicare & Medicaid Services Division. He represents health care providers, suppliers, and laboratories in complex, government-facing investigations, appeals, and direct litigation, maintaining a practice before the U.S. Supreme Court and other federal courts. Tsui also provides regulatory and compliance counsel to health care and life sciences companies, Medicare Advantage plans, Accountable Care Organizations, and other downstream entities in the insurance markets, with an emphasis on medical device manufacturers that must pivot from FDA approval to payment and reimbursement.

About Greenberg Traurig: Greenberg Traurig, LLP has more than 2650 attorneys in 45 locations in the United States, Europe and the Middle East, Latin America, and Asia. The firm is a 2022 BTI “Highly Recommended Law Firm” for superior client service and is consistently among the top firms on the Am Law Global 100 and NLJ 250. Greenberg Traurig is Mansfield Rule 5.0 Certified Plus by The Diversity Lab. The firm is recognized for powering its U.S. offices with 100% renewable energy as certified by the Center for Resource Solutions Green-e® Energy program and is a member of the U.S. EPA’s Green Power Partnership Program. The firm is known for its philanthropic giving, innovation, diversity, and pro bono. Web: